Ndzhentiks Overview
- Status
-
Private
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$424K
- Investors
-
1
Ndzhentiks General Information
Description
Developer of drugs for tuberculosis. The company develops drugs using a molecular-genetic platform for treating drug-resistant tuberculosis through semiconductor sequencing.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- ul. Aviakonstruktora Mikoyana, 12
- Room 1
- Moscow, 125252
- Russia
Ndzhentiks Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Grant | 02-Dec-2014 | $424K | 00000 | Completed | Startup | |
| 1. Angel (individual) | 02-Dec-2014 | 00000 | 00000 | Completed | Startup |
Ndzhentiks Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Skolkovo Foundation | Limited Partner | 000 0000 | 000000 0 |